Barbara Grace Trumble, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 45 E Mills St, Columbus, NC 28722 Phone: 828-894-8213 Fax: 828-894-5775 |
Deborah Gail K. Charnley, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 589 Peniel Rd, Columbus, NC 28722 Phone: 828-894-8213 |
Michelle Marino, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 617 Laurel Lake Dr, Columbus, NC 28722 Phone: 828-894-3446 Fax: 828-894-5926 |
Colden O'dell, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Forest Glen Rd, Ste B, Columbus, NC 28722 Phone: 828-894-5627 |
Carolyn J Carter, N.P. Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 130 Forest Glen Rd, Columbus, NC 28722 Phone: 828-894-7000 Fax: 828-894-2254 |
Casey Collins Harris, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 54 Hospital Dr Ste 3b, Columbus, NC 28722 Phone: 828-894-3230 |
Miss Mary Ann Spake, NP-C Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 89 West Mills Street, Columbus, NC 28722 Phone: 828-894-0377 Fax: 828-894-0760 |
News Archive
Chesapeake Urology Associates, PA, the premier urology practice in Maryland and the Mid-Atlantic region, introduces Chesapeake Urology for Kids, a comprehensive program to treat urologic conditions in children from pre-natal to 18 years of age. This new division is being led by Robert Mevorach, MD, a fellowship trained pediatric urologist. An office exclusively for pediatric patients is now open at 25 Crossroads Drive in Owings Mills, Maryland.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc.
Pediatrics researchers at The Children's Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child's risk for type 1 diabetes, formerly called juvenile diabetes.
Lawmakers are considering how health care reform will change their prospects for office as some tout the law amid threats from the public.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.
› Verified 2 days ago